Mar 30, 2020 2:49 PM
BACK TO TOP
KSE100
28,038.81
-70.76
(-0.25%)
ALLSHR
20,374.46
-110.77
(-0.54%)
KSE30
12,292.05
-28.19
(-0.23%)
KMI30
42,990.94
-64.30
(-0.15%)
BKTi
9,735.10
-95.75
(-0.97%)
OGTi
9,453.49
-430.59
(-4.36%)
KMIALLSHR
13,165.66
-63.66
(-0.48%)
UPP9
8,885.65
52.32
(0.59%)
NITPGI
6,499.98
-36.02
(-0.55%)
Abbott Laboratories (Pakistan) Limited
PHARMACEUTICALS
Rs.315.00
5.05
(1.63%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Mar 30, 2020 2:43 PM
REG
FUT
ODL
Open
320.00
High
320.00
Low
313.03
Volume
19,100
CIRCUIT BREAKER
286.70 — 333.20
DAY RANGE
313.03 — 320.00
52-WEEK RANGE
302.10 — 648.99
Ask Price
315.99
Ask Volume
100
Bid Price
314.06
Bid Volume
100
LDCP
309.95
VAR
14.30
HAIRCUT
19.25
P/E Ratio (TTM)
23.72
1-Year Change *
-50.78%
YTD Change *
-29.50%
Open
320.00
High
333.00
Low
320.00
Close
326.00
Change
7.61%
LDCP
309.95
Volume
192
Total Trades
6
CIRCUIT BREAKER
278.96 — 340.95
DAY RANGE
320.00 — 333.00
Ask Price
333.00
Ask Volume
12
Bid Price
315.00
Bid Volume
1
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Abbott Laboratories (Pakistan) Limited (the Company) is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of research based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

KEY PEOPLE
Mr. Munir A. ShaikhChairman
Mr. Syed Anis AhmedCEO
Mr. Humayun AltafCompany Secretary
ADDRESS

Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi, Pakistan

WEBSITE

www.pk.abbott

REGISTRAR

FAMCO Associates (Pvt) Limited, 8-F, Next to Hotel Faran, Nursery Block 6, P.E.C.H.S, Shahrah-e-Faisal,Karachi

AUDITOR

EY Ford Rhodes, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
30,838,595.13
Shares
97,900,302
Free Float
21,024,895
Free Float
21.48%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Mar 27, 2020Transmission of Annual Report for the Year ended December 31st,2019 View   PDF
Mar 2, 2020Financial Results for the year ended 2019-12-31 View   PDF
Oct 17, 2019Financial Results For The 3rd Quarter View   PDF
Aug 16, 2019Financial Results for the Quarter ended June 30, 2019 View   PDF
Apr 30, 20191st Quarter Accounts for the period ended March 31, 2019 View   PDF
Apr 23, 2019Financial Results for the 1st Quarter ended 2019-03-31 View   PDF
Mar 29, 2019Annual Report for the year ended December 31, 2018 View   PDF
Feb 21, 2019Financial Rsults for year ended December 31 2018 View   PDF
Oct 26, 2018Quarterly Report for the period ended September 30, 2018 View   PDF
Aug 17, 2018Financial Results for the half year ended June 30 2018 View   PDF
DateTitleDocument
Mar 18, 2020Notice of Annual General Meeting View   PDF
Feb 24, 2020Board Meeting View   
Oct 10, 2019Board Meeting View   
Aug 9, 2019Board Meeting View   
Apr 16, 2019Board Meeting View   
Mar 20, 2019Notice of Annual General Meeting View   PDF
Feb 14, 2019Board of Directors Meeting View   
Oct 12, 2018Board Meeting View   
Aug 10, 2018Board Meeting View   
Apr 16, 2018Board Meeting View   
DateTitleDocument
Mar 30, 2020Dissemination of the Annual Report of Abbott Laboratories Pakistan Limited View   PDF
Jan 17, 2020Appointment of Company Secretary View   PDF
Jan 17, 2020Change of Company Secretary View   PDF
Nov 11, 2019Corporate Briefing Session View   PDF
Oct 29, 20193rd Quarter Report View   PDF
Aug 27, 2019Transmission of Quarterly Report View   PDF
May 14, 2019Credit of Final Cash Dividend View   
Oct 19, 2018Financail Results for the 3rd Quarter 2018 View   PDF
Sep 25, 2018Credit of Interim Cash Dividend View   
Aug 29, 2018Transmission of 2nd Quarter Report View   PDF
May 18, 2018Credit of Final Cash Dividend View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales30,155,87529,719,27926,088,23323,387,915
Profit after Taxation1,299,8852,694,3334,205,2324,021,792
EPS13.2827.5242.9541.08
Q3 2019Q2 2019Q1 2019
Sales6,974,8318,089,7237,215,799
Profit after Taxation265,791178,777327,669
EPS2.711.833.35
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)28.2832.8938.6740.05
Net Profit Margin (%)4.319.0716.1217.20
EPS Growth (%)(51.74)(35.93)4.5512.12
PEG(0.66)(0.64)3.571.92

Payouts

DateFinancial ResultsDetailsBook Closure
March 2, 2020 3:11 PM31/12/2019(YR) 75%(F) (D) 11/04/2020 - 19/04/2020
February 21, 2019 3:04 PM31/12/2018(YR) 100%(F) (D) 16/04/2019 - 23/04/2019
August 17, 2018 3:07 PM30/06/2018(HYR) 100% (D) 04/09/2018 - 11/09/2018
February 26, 2018 3:36 PM31/12/2017(YR) 300% (D) 14/04/2018 - 23/04/2018
August 21, 2017 3:09 PM30/06/2017(HYR) 100% (D) 08/09/2017 - 15/09/2017
February 27, 2017 5:03 PM31/12/2016(YR) 300% (D) 11/04/2017 - 18/04/2017
August 19, 2016 3:32 PM30/06/2016(HYR) 100% (D) 06/09/2016 - 16/09/2016
February 19, 2016 4:19 PM31/12/2015(YR) 200% (D) 14/04/2016 - 21/04/2016
August 17, 2015 1:36 PM30/06/2015(HYR) 100% (D) 04/09/2015 - 11/09/2015
February 24, 2015 1:46 PM31/12/2014(YR) 48% (D) 16/04/2014 - 23/04/2014

Financial Reports